Trinity Biotech plc

The momentum for this stock is not very good. Trinity Biotech plc is not a good value stock. Trinity Biotech plc is not very popular among insiders. Trinity Biotech plc is a mediocre stock to choose.

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic pro...

News

Will Trinity Biotech Stock Gain From Its Latest Patent Process?

Benzinga Trinity Biotech plc (NASDAQ: TRIB) recently provided an update on its continued development of its glucose biosensor technology. Earlier this year, the company was granted a European patent for a novel method that enhances the performance of its glucose biosensor.\n more…

Trinity Biotech updates glucose monitor technology evelopment

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Globe Newswire DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions...\n more…

Trinity Biotech names Adrian Donohue as Chief Commercial Officer

Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com

Ticker Report StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB - Get Free Report) in a research report issued on Friday. The brokerage set a "buy" rating on the stock. Trinity Biotech Stock...\n more…

Trinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB - Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a buy rating on the...\n more…